RxDoctor Payments Data

Chelsea Gray, APRN

Psychiatric/Mental Health · Ulysses, KSNPI 1801411731

Payments from drug & device makers

$522in general payments, 2019–2025

Across 21 payments — averaging $24.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$138
  • Teva Pharmaceuticals USA, Inc.$129
  • AbbVie$63
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$49
  • Otsuka America Pharmaceutical, Inc.$25
  • Collegium Pharmaceutical, Inc.$25
  • plus $93 from 6 others

What the payments were for

  • Food & beverage$33564%
  • Education$18636%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$522 in reported general payments places this provider in the 45th percentile of 404 psychiatric/mental health providers in Kansas.

See all psychiatric/mental health providers in Kansas

Medicare billing

Part B allowed, 2024
$17,834
Medicare patients
44
Services billed
229

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega TrinzaPaliperidone Palmitate14$121,149
VraylarCariprazine Hcl65$103,423
Invega SustennaPaliperidone Palmitate16$40,911
SuboxoneBuprenorphine Hcl/Naloxone Hcl14$10,175
Paliperidone ErPaliperidone16$10,083
Lurasidone Hcl28$7,790
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl41$6,154
VyvanseLisdexamfetamine Dimesylate11$4,150
Duloxetine Hcl121$4,073
Olanzapine OdtOlanzapine22$2,771
Lisdexamfetamine Dimesylate12$2,722
Mirtazapine69$1,960
Aripiprazole61$1,845
Quetiapine Fumarate ErQuetiapine Fumarate32$1,731
Bupropion XlBupropion Hcl76$1,485

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Trinza, Invega Sustenna$138$162,06030 claims
AbbVieVraylar$63$103,42365 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 404 psychiatric/mental health providers in Kansas.

Other psychiatric/mental health in Ulysses

See the full list for Kansas

Where these figures come from

Is this you, or does something look wrong? →